LncRNA SNHG16 induces proliferation and fibrogenesis via modulating miR-141-3p and CCND1 in diabetic nephropathy

[1]  A. Thiel,et al.  MicroRNA‐487a‐3p functions as a new tumor suppressor in prostate cancer by targeting CCND1 , 2020, Journal of cellular physiology.

[2]  Zujiang Yu,et al.  Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma. , 2019, Experimental cell research.

[3]  L. Medeiros,et al.  Utility of Cyclin D1 in the Diagnostic Workup of Hematopoietic Neoplasms: What Can Cyclin D1 do for Us? , 2019, Advances in anatomic pathology.

[4]  A. Awasthi,et al.  Emerging roles of noncoding RNAs in T cell differentiation and functions in autoimmune diseases , 2019, International reviews of immunology.

[5]  Ting-ting Guo,et al.  lncRNA MALAT1 mediated high glucose–induced HK-2 cell epithelial-to-mesenchymal transition and injury , 2019, Journal of Physiology and Biochemistry.

[6]  Dong-wei Liu,et al.  Silencing of long noncoding RNA PVT1 inhibits podocyte damage and apoptosis in diabetic nephropathy by upregulating FOXA1 , 2019, Experimental & Molecular Medicine.

[7]  C. Pérez-Plasencia,et al.  Crosstalk Between Long Non-coding RNAs, Micro-RNAs and mRNAs: Deciphering Molecular Mechanisms of Master Regulators in Cancer , 2019, Front. Oncol..

[8]  Qiang Zhou,et al.  Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma , 2019, BMC cancer.

[9]  Yan Zhang,et al.  LncRNA SOX2OT alleviates the high glucose-induced podocytes injury through autophagy induction by the miR-9/SIRT1 axis. , 2019, Experimental and molecular pathology.

[10]  H. Liu,et al.  LncRNA TCF7 triggered endoplasmic reticulum stress through a sponge action with miR-200c in patients with diabetic nephropathy. , 2019, European review for medical and pharmacological sciences.

[11]  R. Müller,et al.  Long Non-Coding RNAs in Kidney Disease , 2019, International journal of molecular sciences.

[12]  L. Qin,et al.  Long noncoding RNAs, emerging and versatile regulators of tumor-induced angiogenesis. , 2019, American journal of cancer research.

[13]  Shaoqiong Liu,et al.  MiR-141-3p inhibits cell proliferation, migration and invasion by targeting TRAF5 in colorectal cancer. , 2019, Biochemical and biophysical research communications.

[14]  Yongli Guo,et al.  lncRNA SNHG16 is associated with proliferation and poor prognosis of pediatric neuroblastoma , 2019, International journal of oncology.

[15]  Yan Li,et al.  Roles of Identified Long Noncoding RNA in Diabetic Nephropathy , 2019, Journal of diabetes research.

[16]  Jianning Yao,et al.  microRNA-141-3p fosters the growth, invasion, and tumorigenesis of cervical cancer cells by targeting FOXA2. , 2018, Archives of biochemistry and biophysics.

[17]  Man-gen Song,et al.  MicroRNA-141-3p/200a-3p target and may be involved in post-transcriptional repression of RNA decapping enzyme Dcp2 during renal development , 2018, Bioscience, biotechnology, and biochemistry.

[18]  M. Kuo,et al.  Angiopoietin-2, Renal Deterioration, Major Adverse Cardiovascular Events and All-Cause Mortality in Patients with Diabetic Nephropathy , 2018, Kidney and Blood Pressure Research.

[19]  Li-ping Zhu,et al.  Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway , 2018, Biological Research.

[20]  Andrea Knau,et al.  The lncRNA GATA6-AS epigenetically regulates endothelial gene expression via interaction with LOXL2 , 2018, Nature Communications.

[21]  Runsheng Chen,et al.  Mesenchymal Stem Cells Promote Hepatocarcinogenesis via lncRNA-MUF Interaction with ANXA2 and miR-34a. , 2017, Cancer research.

[22]  P. Ramos-García,et al.  An update on the implications of cyclin D1 in oral carcinogenesis. , 2017, Oral diseases.

[23]  J. DiStefano,et al.  Long noncoding RNAs in the pathogenesis of diabetic kidney disease: implications for novel therapeutic strategies. , 2017, Personalized medicine.

[24]  Xiaolong Wang,et al.  SNHG16 contributes to breast cancer cell migration by competitively binding miR-98 with E2F5. , 2017, Biochemical and biophysical research communications.

[25]  O. Barbier,et al.  Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay , 2017, Hepatology.

[26]  Jakob Skou Pedersen,et al.  SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism , 2016, Molecular oncology.

[27]  X. Wang,et al.  A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA , 2014, Oncogene.

[28]  P. Oates.  Aldose reductase inhibitors and diabetic kidney disease. , 2010, Current opinion in investigational drugs.

[29]  Chenguang Wang,et al.  Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells. , 2010, Cancer research.

[30]  C. Ponting,et al.  Evolution and Functions of Long Noncoding RNAs , 2009, Cell.

[31]  Amanda Y. Chan,et al.  Cyclin D1 governs adhesion and motility of macrophages. , 2003, Molecular biology of the cell.

[32]  Guang-Wei Wang,et al.  lncRNA SNHG16 promotes glioma tumorigenicity through miR-373/EGFR axis by activating PI3K/AKT pathway. , 2019, Genomics.

[33]  M. L. Alvarez,et al.  The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression. , 2013, Diabetes research and clinical practice.